Document text
Principal Investigator: George A. Belov
Organization: UNIV OF MARYLAND, COLLEGE PARK
Fiscal Year: 2020
Award: $189,608
Funding agency: National Institute of Allergy and Infectious Diseases
Multiple enteroviruses are associated with life-threatening and economically important diseases, yet the
licensed vaccines are only available against poliovirus and enterovirus 71. The antigenic diversity of
enterovirus capsids restricts the protective efficacy of vaccines only to antigenically very similar viruses. Even
for closely related polioviruses, the three serotypes must be covered by separate vaccine products. In most
cases such targeted vaccine development approach cannot even be implemented, either because of the
biological constraints, such as antigenic diversity of rhinoviruses, or economic unattractiveness of developing
vaccines against viruses only sporadically associated with severe pathologies, such as Coxsackie viruses
linked to the development of diabetes, myocarditis and dilated cardiomyopathy. Thus, in spite of a pressing
need for an effective vaccine coverage of existing and emerging enterovirus threats, the current
vaccine development strategies focused on inducing neutralizing antibodies against capsid antigens
are intrinsically incapable of delivering products meeting this demand.
Yet, unlike the antigenically diverse capsids, the non-structural proteins of these viruses feature a significant
degree of conservation, so that the elements of the replication machinery are essentially interchangeable
among diverse enteroviruses, resulting in the phenomenon of extensive recombination of enterovirus
genomes.
In this application we present data to support, and propose to explore the hypothesis that posits the following:
Antigenically diverse enteroviral capsids are immuno-dominant antigens which divert the development
of immune response away from the conserved non-structural proteins. Consequently, by removing the
input of the capsid proteins, the development of the immune response to enterovirus infection can be rerouted
towards the conserved membrane-associated proteins of the replication machinery. likely resulting in: 1.
Refocusing the protection mechanism from that based mostly on neutralizing antibodies to the one
mediated by T-cell cytotoxicity, and 2. Providing protection against broad spectrum of enteroviruses.
Terms: <Acute Poliomyelitis><Amino Acid Sequence><Antibodies><Antigenic Diversity><Antigens><Asthma><Attenuated Vaccines><Biological><Brittle Diabetes Mellitus><Bronchial Asthma><CD8><CD8B><CD8B1><CD8B1 gene><Capsid><Capsid Proteins><Cell Body><Cell-Mediated Lympholytic Cells><Cells><China><Coat Proteins><Code><Coding System><Congestive Cardiomyopathy><Coxsackie Viruses><Coxsackievirus><Cytolytic T-Cell><Cytotoxic T Cell><Cytotoxic T-Lymphocytes><DNA Recombination><Data><Development><Diabetes Mellitus><Dilated Cardiomyopathy><Disease><Disease Outbreaks><Disorder><Economic Burden><Economics><Elements><Encephalomyelitis><Enterovirus><Enterovirus 68><Enterovirus 71><Enterovirus D68><Enterovirus Infections><Epidemiology><Family Picornaviridae><Flavivirus><Gene Pool><Genetic Recombination><Genome><Group B Arbovirus><Health Resources><Human poliovirus><IDDM><Immune response><Immunity><Immunization><Immunize><Immunodominant Antigens><Immunologic Sensitization><Immunologic Stimulation><Immunological Sensitization><Immunological Stimulation><Immunological response><Immunostimulation><In Vitro><Inactivated Vaccines><Inactivated Virus Vaccine><Individual><Infection><Insulin-Dependent Diabetes Mellitus><Juvenile-Onset Diabetes Mellitus><Ketosis-Prone Diabetes Mellitus><Killed Vaccines><LYT3><Life><Link><Lytotoxicity><Mainland China><Mediating><Membrane Protein Gene><Membrane Proteins><Membrane-Associated Proteins><Mice><Mice Mammals><Murine><Mus><Myeloencephalitis><Myocarditis><Non-Polyadenylated RNA><Non-structural Protein><Nonstructural Protein><Oral><Oral Polio Vaccine><Oral Poliovirus Vaccine><Outbreaks><Palsy><Paralysed><Pathology><Phase><Picornaviridae><Picornaviruses><Plegia><Polio><Polio Vaccine><Polio Virus><Poliomyelitis><Poliovirus><Poliovirus Vaccines><Primary Protein Structure><Primates><Primates Mammals><Property><Proteins><Public Health><RNA><RNA Gene Products><RNA Viruses><Recombination><Replication Unit><Replicon><Rhinovirus><Ribonucleic Acid><Role><Sabin Vaccine><Salk Vaccine><Scheme><Serotyping><Specificity><Stretching><Structure><Sudden-Onset Diabetes Mellitus><Surface Proteins><System><T cell response><T-Cells><T-Lymphocyte><T1 DM><T1 diabetes><T1D><T1DM><Time><Type 1 Diabetes Mellitus><Type 1 diabetes><Type I Diabetes Mellitus><Vaccination><Vaccines><Viral><Viral Coat Proteins><Viral Gene Products><Viral Gene Proteins><Viral Outer Coat Protein><Viral Proteins><Virion><Virus><Virus Particle><Virus-like particle><antigen-specific T cells><base><cardiac inflammation><cytotoxic><cytotoxicity><develop a vaccine><development of a vaccine><developmental><diabetes><epidemiologic><epidemiological><host response><human pathogen><immunogen><immunoresponse><in vivo><insulin dependent diabetes><juvenile diabetes><juvenile diabetes mellitus><ketosis prone diabetes><killer T cell><live vaccine><meetings><mouse model><murine model><neutralizing antibody><novel><paralysis><paralytic><pathogen><poliomyelitis vaccine><poliomyelitis virus><prevent><preventing><product development><protective efficacy><protein sequence><response><social role><thymus derived lymphocyte><type I diabetes><type one diabetes><vaccine development><vaccine efficacy><vaccine formulation><virus protein><virus-like nanoparticles><viruslike particle>